Reported Standalone quarterly numbers for Parmax Pharma are: Net Sales at Rs 9.28 crore in September 2024 up 128.05% from Rs. 4.07 crore in September 2023. Quarterly Net Loss at Rs. 0.22 crore in September 2024 up 84.14% from Rs. 1.37 crore in September 2023. EBITDA stands at Rs. 0.31 crore in September 2024 up 140.79% from Rs. 0.76 crore in September 2023.
Open FlipBSE share price advanced over 4 percent in November 25 trade on introduction of futures and options (F&O) contracts for 43 stocks. The information was disclosed post market hours on November 22 by the exchange. BSE stock surged 4.5 percent to its intraday high of Rs 4,933 per share on the NSE. At around 12 pm, the stock quoted at Rs 4,845.70 apiece, up 2.66 percent.
Open FlipReported Standalone quarterly numbers for Brawn Biotech are: Net Sales at Rs 3.30 crore in September 2024 up 12.95% from Rs. 2.92 crore in September 2023. Quarterly Net Loss at Rs. 0.34 crore in September 2024 up 18.67% from Rs. 0.42 crore in September 2023. EBITDA stands negative at Rs. 0.31 crore in September 2024 up 20.51% from Rs. 0.39 crore in September 2023.
Open Flip